Genentech

A daily roundup of news on COVID-19 and the rest of medicine

The nonprofit organization aims to boost awareness and interest around clinical trial research through FREE interactive, educational events

ICMs detect atrial fibrillation (AF) more often than standard care does among patients with recent ischemic stroke linked to small-vessel occlusion or large-vessel atherosclerosis, the STROKE AF trial shows.

Blacks make up only about 6% of participants in clinical trials.

In The Code Breaker , distinguished historian and biographer Walter Isaacson tells the life story of biochemist Jennifer Doudna, who played a major role in discovering the inner workings of the gene editing tool CRISPR-Cas9. Doudna's story is compelling and intersects with others, including French scientist Emmanuelle Charpentier, with whom Doudna shared the 2020 Nobel Prize in Chemistry, and notable figures in…

A study of post–COVID-19 patients in the UK who developed severe lung inflammation after they left the hospital may provide greater clarity on which patients are most likely to have persistent lung dysfunction.

With lots of research, arrows, and an inviting color palette, artists helped transform complex research into useful information.

A daily roundup of news on COVID-19 and the rest of medicine

Long-term collaboration underpins BioNTech's strategy to leverage Artificial Intelligence (AI) and Machine Learning (ML) technologies to support the...

Even the worst-run startup can beat competitors if investors prop it up. The V.C. firm Benchmark helped enable WeWork to make one wild mistake after another—hoping that its gamble would pay off before disaster struck, Charles Duhigg writes.

David J. Dykeman, co-managing shareholder of global law firm Greenberg Traurig, LLP's Boston office and co-chair of the firm's global Life Sciences & Medical Technology Group, will be a speaker during American Conference Institute's (ACI) 4th Annual Summit on Life Sciences IP Due Diligence, taking place virtually Nov. 9-10, 2020.

ISPE installed its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo.

The bureaucratic mindset—self-protection at the expense of the public interest—got in the way.

Efficacy and safety of atezolizumab as first-line therapy for metastatic non–small cell lung cancer (NSCLC) with high levels of PD-L1 expression is not known, the authors said.

Why Silicon Valley CEOs — and their employees — are driven by some of the worst behavior known to man.

Satralizumab becomes the third neuromyelitis optica spectrum disorder drug approved

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Evr

BioNTech has partnered with Pfizer to develop a coronavirus vaccine that may be ready by the end of 2020.

News, features, and commentary about cancer-related issues

How to start a biotech startup, adapted from interviews with the founders of Genentech.